Abstract
Author's reply to A. J. Forbes, “Letter: Extending the Measurement of Inflammatory Bowel Disease Severity to Include Patient Important Outcomes,” Alimentary Pharmacology & Therapeutics (2024): 1–2, https://doi.org/10.1111/apt.18410 regarding their article A. Swaminathan, A. S. Day, M. P. Sparrow, L. Peyrin-Biroulet, C. A. Siegel, and R. B. Gearry, “Review Article: Measuring Disease Severity in Inflammatory Bowel Disease – Beyond Treat to Target,” Alimentary Pharmacology & Therapeutics 60, no. 9 (2024): 1176–1199.